1. Home
  2. FARM vs INAB Comparison

FARM vs INAB Comparison

Compare FARM & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmer Brothers Company

FARM

Farmer Brothers Company

HOLD

Current Price

$1.25

Market Cap

27.0M

ML Signal

HOLD

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$1.50

Market Cap

22.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FARM
INAB
Founded
1912
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.0M
22.9M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
FARM
INAB
Price
$1.25
$1.50
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$2.75
$6.00
AVG Volume (30 Days)
465.8K
61.6K
Earning Date
05-07-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$342,281,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.35
N/A
52 Week Low
$1.21
$0.12
52 Week High
$2.32
$4.20

Technical Indicators

Market Signals
Indicator
FARM
INAB
Relative Strength Index (RSI) 35.59 39.15
Support Level $1.21 $1.17
Resistance Level $1.59 $2.14
Average True Range (ATR) 0.02 0.20
MACD 0.01 -0.03
Stochastic Oscillator 70.00 5.30

Price Performance

Historical Comparison
FARM
INAB

About FARM Farmer Brothers Company

Farmer Bros Co is engaged in manufacturing, wholesaling, and distributing coffee, tea, and culinary products to food-service establishments and retailers in the United States. The company's customers include restaurants, hotels, offices, casinos, convenience stores, healthcare facilities, and other food-service providers. The company's product categories include roast and ground coffee, frozen liquid coffee, flavored and unflavored iced and hot teas, culinary products, spices, and other beverages, such as cappuccino, cocoa, granitas, and ready-to-drink iced coffee.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

Share on Social Networks: